APR 11, 2018 9:00 AM PDT

Genomic profiling in Community Practice: Ensuring the Right Test for the Right Patient Every Time

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services, PathGroup
    Biography
      Dr. Chandra, is currently the Chief Medical Officer of Genomic and Clinical Pathology Services at PathGroup. Dr. Chandra holds board certifications in anatomic and clinical pathology, hematopathology and molecular genetic pathology. He completed his AP/CP training and fellowships in hematopathology, oncologic pathology and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center. While at MD Anderson, he served as Chief Fellow and received numerous awards for his research on translocation t(9;11) associated acute myeloid leukemia. Dr. Chandra joined PathGroup in 2011 as Associate Medical Director of Molecular Pathology and became Director in March of 2013. He has presented numerous abstracts and platform presentations at various pathology meetings, published articles in peer-reviewed journals and composed a book chapter on cutaneous T-cell lymphomas. Dr. Chandra is a member of the American Society of Clinical Pathology, Association of Molecular Pathology where he also serves on the Economic Affairs Committee and Clinical Practice Committee. Dr. Chandra also serves on the Personalized Healthcare Committee through the College of American Pathologists. Dr. Chandra is a medical consultant in molecular pathology and personalized medicine and is considered a national thought leader in Precision Oncology and Cancer Genomics.

    Abstract:

    Genomic profiling in various cancers has become standard of care today.  Dr. Chandra will discuss the challenges and opportunities of precision oncology testing in community practice and will highlight key learning objectives through case studies.  


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources